Cargando…
Progestogens as a component of menopausal hormone therapy: the right molecule makes the difference
Optimizing menopausal hormone therapy (MHT) requires an awareness of the benefits and risks associated with the available treatments. This narrative review, which is based on the proceedings of an Advisory Board meeting and supplemented by relevant articles identified in literature searches, examine...
Autores principales: | Stevenson, John C, Rozenberg, Serge, Maffei, Silvia, Egarter, Christian, Stute, Petra, Römer, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioExcel Publishing Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716720/ https://www.ncbi.nlm.nih.gov/pubmed/33312219 http://dx.doi.org/10.7573/dic.2020-10-1 |
Ejemplares similares
-
Progestogens in menopausal hormone therapy
por: Bińkowska, Małgorzata, et al.
Publicado: (2015) -
Menopausal hormone therapy and breast cancer risk: All progestogens are not the same
por: Lambrinoudaki, Irene
Publicado: (2020) -
Estetrol Combined to Progestogen for Menopause or Contraception Indication Is Neutral on Breast Cancer
por: Gallez, Anne, et al.
Publicado: (2021) -
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
por: Deng, Yu, et al.
Publicado: (2022) -
Progesterone and progestogens
por: Lipinski, Joanne
Publicado: (2022)